✦ LIBER ✦

Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: A meta-analysis

✍ Scribed by Calogero Cammà; Giuseppe Cabibbo; Fabrizio Bronte; Marco Enea; Anna Licata; Massimo Attanasio; Angelo Andriulli; Antonio Craxì

Book ID: 116651976
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 183 KB
Volume: 51
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2009.06.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Retreatment of patients with chronic hep

Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine

✍ Rudolf E Stauber; Harald Hofer; Franz Hackl; Kurt Schüze; Christian Datz; Karin 📂 Article 📅 2004 🏛 Springer Vienna 🌐 English ⚖ 738 KB

Interferon versus ribavirin plus interfe

Interferon versus ribavirin plus interferon in chronic hepatitis C patients relapsers and non responders to recombinant interferon

✍ C. Vandelli; F. Renzo; E. Lovato; C. Sardini; G. Di Marco; S. Tisminetzky; E Ven 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Pegylated α-interferon-2a plus ribavirin

Pegylated α-interferon-2a plus ribavirin compared with pegylated α-interferon-2b plus ribavirin for initial treatment of chronic hepatitis C virus: Prospective, non-randomized study

✍ Amparo Escudero; Felicidad Rodríguez; Miguel A Serra; Juan A Del Olmo; Francisco 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Retreating chronic hepatitis C with dail

Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results

✍ Bruce R. Bacon; Mitchell L. Shiffman; Flavia Mendes; Reem Ghalib; Tarek Hassanei 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 1 views

Up to 50% of patients with chronic hepatitis C fail to respond to initial therapy with pegylated interferon (PEG-IFN) and ribavirin (RBV). With unsuccessful viral eradication, these patients remain at risk for developing progression of their liver disease. Retreatment with PEG-IFN/RBV yields sustain

Controlled trial with pegylated interfer

Controlled trial with pegylated interferon-alpha2b plus ribavirin retreatment in patients with chronic hepatitis C not responding to a previous antiviral treatment with standard interferons combined with ribavirin

✍ G. Teuber; B. Kallinowski; C. Niederau; H. Klinker; P.R. Galle; M. Zankel; S. Ze 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Ribavirin interferon combination in pati

Ribavirin interferon combination in patients with chronic hepatitis C non responders to interferon:

✍ M. Diago; MD. Valeros; M. Lujan; R. Cors; P. Carbonell; V. Garcia; R. Zapater; C 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 155 KB